Bio-Techne Awards Cancer Researcher $40,000 Grant

Monday, November 13, 2017 - 21:58
Behren Get Hybridized Recipient from ACD Bio

Advanced Cell Diagnostics, a Bio-Techne Brand, completed a yearlong 'RNAscope ISH Get Hybridized' giveaway awarding Dr. Andreas Behren from the Olivia Newton-John Cancer Research (ONJCRI) Institute in Melbourne, Australia the grand prize of $40,000 grant to support his research in Cancer Immunobiology.

Several thousand researchers from around the world participated in the year-long giveaway by describing their research and its impact, as well as a potential role for RNAscope ISH.

The grant was presented at the Bio-Techne Wax Museum Party at the Society for Neuroscience 2017 Annual Meeting in Washington DC on November 13, 2017.

At the event, Dr. Behren explained the utility of RNAscope in his research:

"Using RNAscope, we hope to track and visualize antigen-specific T cells in situ and profile their activation status and immune-checkpoint expression pattern. With this information, it would be possible to determine the activation profile of tumor-specific T cells and their location within the tumor-microenvironment in FFPE tissues. Hopefully, this will reveal novel targetable mechanisms that contribute to resistance to immunotherapies."

For more information about the work of Dr. Andreas Behren, ACD Bio’s Get Hybridized giveaway and how RNAScope can help your research, read the full press release here.